• Osteoblast ECM1 Drives Anti-Androgen Resistance in Bone Meta

  2026-05-15

  This study reveals that osteoblast-derived ECM1, secreted in response to enzalutamide therapy, promotes anti-androgen resistance in bone metastatic prostate cancer via activation of the ENO1-MAPK signaling axis. The findings highlight ECM1 and ENO1 as promising therapeutic targets and provide mechanistic insight into tumor-stromal interactions fueling therapy resistance.

• Cholecystokinin Octapeptide Ammonium: Decoding Neuroimmune M

  2026-05-14

  Explore the multifaceted mechanisms and advanced applications of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) in neurobehavioral and immune research. This in-depth guide reveals how CCK-8 ammonium enables precise modulation of anxiety-like behavior and immune responses, filling critical knowledge gaps for translational and preclinical assay design.

• Bifendate Inhibits Autophagy and Reduces Lipid Droplet Accum

  2026-05-14

  This study reveals that bifendate (DDB), a hepatoprotective agent, inhibits autophagy at multiple stages and attenuates oleic acid-induced lipid droplet accumulation in cultured cells. The findings provide new mechanistic insights into DDB's action and highlight its potential in modulating lipid metabolism and autophagy-linked liver pathology.

• Peroxidasin Drives Glycolytic Shift and Malignancy in Gliobl

  2026-05-13

  This study identifies peroxidasin (PXDN) as a key regulator of glycolytic metabolism in glioblastoma, acting through LDHA to accelerate tumor progression. The findings highlight PXDN as a potential diagnostic marker and therapeutic target, with implications for metabolic intervention strategies in aggressive brain tumors.

• Imatinib Hydrochloride: Precision Kinase Inhibition in Oncol

  2026-05-13

  Explore how Imatinib hydrochloride (STI571 hydrochloride) enables precision targeting of tyrosine kinases in cancer research. This article reveals new mechanistic insights, practical assay guidance, and a critical perspective on dual-action kinase inhibitors.

• Estradiol and the Estrogen Receptor–Autophagy Axis: Translat

  2026-05-12

  This thought-leadership article dissects the mechanistic and strategic landscape of 17 beta-estradiol in translational research, focusing on the estrogen receptor–autophagy axis for organ protection. It integrates recent evidence from human cohorts and preclinical models, offers protocol-level guidance, evaluates the competitive research landscape, and positions APExBIO Estradiol as a precision reagent for advanced experimental workflows.

• Taltirelin Acetate: Mechanism, Benchmarks, and Research Uses

  2026-05-12

  Taltirelin acetate is a long-acting TRH analog with verified neuroprotective and neuromodulatory actions. It acts as a selective TRH receptor 1 agonist, modulating dopamine transporter activity and inhibiting MAO-B. Preclinical research demonstrates its potential for Parkinson’s, itch, and obstructive sleep apnea models.

• GSK2606414: Selective PERK Inhibitor for Reliable ER Stress

  2026-05-11

  This article addresses key experimental challenges in ER stress, cell viability, and cytotoxicity assays, demonstrating how GSK2606414 (SKU A3448) from APExBIO delivers reproducible, data-driven solutions. Evidence-based scenarios and protocol insights empower biomedical researchers to optimize unfolded protein response modulation in cancer and neurodegenerative disease models.

• QPRT Drives Breast Cancer Invasion via P2Y11 and Myosin Path

  2026-05-11

  Liu et al. (2021) reveal that quinolinate phosphoribosyltransferase (QPRT) promotes breast cancer invasiveness through phosphorylation of myosin light chain, acting upstream in a pathway involving P2Y11 receptor signaling. Pharmacological inhibition of P2Y11, including with compounds such as NF 340, reverses these invasive phenotypes, highlighting new mechanistic links between metabolic enzymes, purinergic GPCRs, and cancer cell motility.

• Affinity-Purified Goat Anti-Rabbit IgG (H+L) for Robust Sign

  2026-05-10

  Unlock maximum sensitivity and specificity in your immunoassays with the HRP Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO. This affinity-purified secondary antibody streamlines Western blot, ELISA, and IHC workflows, delivering robust signal amplification and reproducibility even in complex translational research models.

• Polybrene (Hexadimethrine Bromide) 10 mg/mL: Mechanism & Ben

  2026-05-09

  Polybrene (Hexadimethrine Bromide) 10 mg/mL enhances viral gene transduction and lipid-mediated DNA transfection by neutralizing surface charge barriers. APExBIO's K2701 formulation provides reproducible performance for lentivirus and retrovirus workflows, but users must monitor exposure time to prevent cytotoxicity.

• Translating Complex RNA into Discovery: HyperScript™ RT in F

  2026-05-08

  This thought-leadership article bridges mechanistic innovation and translational practice, demonstrating how HyperScript™ Reverse Transcriptase enables precision cDNA synthesis for challenging RNA templates. By integrating recent ophthalmic research and advanced enzyme engineering, it offers strategic insights for researchers confronting low-abundance or highly structured transcripts, with practical guidance and a forward-looking perspective.

• Dacarbazine: Quantitative Drug Response and Assay Precision

  2026-05-08

  Explore the advanced science of Dacarbazine as an antineoplastic chemotherapy drug, focusing on quantitative drug response metrics and assay precision in cancer research. Learn how emerging in vitro evaluation methods enable more reliable decisions for malignant melanoma, Hodgkin lymphoma, and sarcoma models.

• Gramine as a Precision Ferroptosis Inducer in TNBC Research

  2026-05-07

  This thought-leadership article explores the mechanistic basis, translational value, and experimental best practices for leveraging Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a validated ferroptosis inducer targeting the CUL3–MTDH ubiquitination axis in triple-negative breast cancer (TNBC). Anchored in recent peer-reviewed research, the discussion integrates actionable protocol guidance, contextualizes Gramine’s position within the competitive landscape, and projects the implications for next-generation cancer biology workflows.

• V5 Epitope Tag Peptide: Optimizing Protein Tagging Workflows

  2026-05-07

  The V5 Epitope Tag Peptide (GKPIPNPLLGLDST) delivers unmatched specificity and versatility in recombinant protein workflows. This guide details experimental best practices, advanced imaging applications, and troubleshooting strategies that leverage its unique properties for reliable detection, purification, and dynamic molecular interrogation.

414 records 9/28 page Previous Next First page 上5页 678910 下5页 Last page